BioSpace News Archive

Acuamark Diagnostics (“AcuamarkDx”), an early cancer detection company, today announced the closing of an $11.3 million Series A round.

Anodot, the business monitoring company, today announced that the United States Patent and Trademark Office has granted the company a patent for a new algorithm that vastly improves the speed and reduces the computational cost of its anomaly detection offering.

Clarity Pharmaceuticals (ASX: CU6) (“Clarity”), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce the completion of recruitment for the Phase I PROPELLER diagnostic trial evaluating its 64Cu-SAR-bisPSMA product candidate in patients with untreated, confirmed prostate cancer, scheduled for radical prostatectomy.

Encompass Health Corporation announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.15 per share, payable on October 17, 2022, to holders of record on October 3, 2022.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx,”), announced today that it will be hosting a booth to showcase its existing and upcoming suite of diagnostics products and technology applications at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.

The requested amendment and extension is subject to approval from the Exchange.

Masimo (NASDAQ: MASI) today announced the findings of a randomized, controlled trial published in the Journal of Clinical Anesthesia in which Dr. Melody H.Y. Long and colleagues from the KK Women’s and Children’s Hospital in Singapore evaluated the ability of electroencephalogram (EEG)-guided anesthesia, using Masimo SedLine® brain function monitoring, to reduce the amount of the drug sevoflurane needed to maintain anesthesia in pediatric patients undergoing minor surgery.

The report consists of quantitative and qualitative research on the market performed by our market experts.

Scientists at deCODE genetics a subsidiary of Amgen together with collaborators from Denmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in the journal Nature.

Forecast to 2030,’ thoroughly examines the Hypoxia industry to provide essential data & information for the targeted readers.